Fibroblast Growth Factors in the Management of Acute Kidney Injury Following Ischemia-Reperfusion

Fibroblast Growth Factors in the Management of Acute Kidney Injury Following Ischemia-Reperfusion

Ischemia-reperfusion injury (IRI), which is triggered by a transient reduction or cessation of blood flow followed by reperfusion, is a significant cause of acute kidney injury (AKI). IRI can lead to acute cell death, tissue injury, and even permanent organ dysfunction. In the clinic, IRI contribute...

Full description

Bibliographic Details
Main Authors: Lian-Cheng Deng, Tahereh Alinejad, Saverio Bellusci, Jin-San Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Pharmacology
Subjects:
fibroblast growth factors
ischemia-reperfusion injury
acute kidney injury
protection
therapy
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00426/full

Similar Items

Similar Items